{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:17Z","timestamp":1792791017186,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA016086-46S3"],"award-info":[{"award-number":["CA016086-46S3"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["Developmental Award"],"award-info":[{"award-number":["Developmental Award"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["Developmental Award"],"award-info":[{"award-number":["Developmental Award"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["Developmental Award"],"award-info":[{"award-number":["Developmental Award"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Communicable Diseases  (NICD) of South Africa"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The number of people with HIV (PWH) in Africa is rising due to population growth and antiretroviral therapy (ART) availability, with diffuse large B-cell lymphoma (DLBCL) a major cause of mortality. HIV and ART alter DLBCL tumor biology, but few studies of DLBCL include PWH or African patients, limiting translation of emerging treatment strategies. Here, we performed whole exome sequencing of 48 tumors (40 HIV-positive [HIV+]) with paired germline of DLBCL patients from Malawi and South Africa. HIV\u2009+\u2009DLBCL tumors had distinct mutations depending on ART exposure, and there were several recurrent deleterious variants, with\n                    <jats:italic>ANKRD11<\/jats:italic>\n                    mutations being prognostic. One tumor from each cohort had high tumor mutational burden and microsatellite-instability with\n                    <jats:italic>PMS2<\/jats:italic>\n                    and\n                    <jats:italic>ARID1A<\/jats:italic>\n                    mutation. These findings suggest shared genomic characteristics among HIV\u2009+\u2009DLBCL in Africa, offering opportunities for tailored biomarkers and therapeutic targets for this underserved population.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-10529-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:44:54Z","timestamp":1752137094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shared genomic features of HIV+\u2009diffuse large B-cell lymphoma in two African cohorts"],"prefix":"10.1038","volume":"15","author":[{"given":"Sophia M.","family":"Roush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishalan","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amon","family":"Chirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwards","family":"Kasonkanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marriam","family":"Mponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiwe","family":"Tomoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanri","family":"van Zijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hodkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senzo","family":"Mtshali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Featherston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Painschab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"10529_CR1","doi-asserted-by":"publisher","first-page":"839835","DOI":"10.3389\/fpubh.2022.839835","volume":"10","author":"R Sharma","year":"2022","unstructured":"Sharma, R. et al. Mapping Cancer in africa: A comprehensive and comparable characterization of 34 Cancer types using estimates from GLOBOCAN 2020. Front. Public. Health. 10, 839835. https:\/\/doi.org\/10.3389\/fpubh.2022.839835 (2022).","journal-title":"Front. Public. Health"},{"issue":"23","key":"10529_CR2","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1001\/jama.2022.10019","volume":"327","author":"HD Larkin","year":"2022","unstructured":"Larkin, H. D. Cancer deaths May double by 2030 in Sub-Saharan Africa. JAMA 327 (23), 2280. https:\/\/doi.org\/10.1001\/jama.2022.10019 (2022).","journal-title":"JAMA"},{"issue":"9","key":"10529_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jama.2021.12778","volume":"326","author":"S Gopal","year":"2021","unstructured":"Gopal, S. & Sharpless, N. E. Cancer as a global health priority. JAMA 326 (9), 809. https:\/\/doi.org\/10.1001\/jama.2021.12778 (2021).","journal-title":"JAMA"},{"issue":"12","key":"10529_CR4","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/s41436-019-0558-2","volume":"21","author":"A Nugent","year":"2019","unstructured":"Nugent, A. et al. Reporting of race in genome and exome sequencing studies of cancer: a scoping review of the literature. Genet. Sci. 21 (12), 2676\u20132680. https:\/\/doi.org\/10.1038\/s41436-019-0558-2 (2019).","journal-title":"Genet. Sci."},{"issue":"2","key":"10529_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","volume":"28","author":"S Fatumo","year":"2022","unstructured":"Fatumo, S. et al. A roadmap to increase diversity in genomic studies. Nat. Med. 28 (2), 243\u2013250. https:\/\/doi.org\/10.1038\/s41591-021-01672-4 (2022).","journal-title":"Nat. Med."},{"issue":"21","key":"10529_CR6","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1200\/JCO.23.00737","volume":"41","author":"K Lurain","year":"2023","unstructured":"Lurain, K. Treating Cancer in people with HIV. JCO 41 (21), 3682\u20133688. https:\/\/doi.org\/10.1200\/JCO.23.00737 (2023).","journal-title":"JCO"},{"key":"10529_CR7","unstructured":"UNAIDS & Global, A. I. D. S. : The path to ending AIDS as a public health threat by 2030. UNAIDS. Published online July 22, 2024. (2024). https:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2024\/july\/20240722_global-aids-update"},{"issue":"1","key":"10529_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12889-016-3620-x","volume":"16","author":"AD Harries","year":"2016","unstructured":"Harries, A. D. et al. Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy. BMC Public. Health. 16 (1), 938. https:\/\/doi.org\/10.1186\/s12889-016-3620-x (2016).","journal-title":"BMC Public. Health"},{"issue":"1S","key":"10529_CR9","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1097\/QAI.0000000000003326","volume":"95","author":"A Trickey","year":"2024","unstructured":"Trickey, A. et al. Estimation of improvements in mortality in spectrum among adults with HIV receiving antiretroviral therapy in High-Income countries. JAIDS J. Acquir. Immune Defic. Syndr. 95 (1S), e89\u2013e96. https:\/\/doi.org\/10.1097\/QAI.0000000000003326 (2024).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"10529_CR10","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","volume":"72","author":"MJ Horner","year":"2021","unstructured":"Horner, M. J., Shiels, M. S., Pfeiffer, R. M. & Engels, E. A. Deaths attributable to Cancer in the US human immunodeficiency virus population during 2001\u20132015. Clin. Infect. Dis. 72 (9), e224\u2013e231. https:\/\/doi.org\/10.1093\/cid\/ciaa1016 (2021).","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10529_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan, R. & Uldrick, T. S. HIV-Associated cancers and related diseases. N Engl. J. Med. 378 (11), 1029\u20131041. https:\/\/doi.org\/10.1056\/NEJMra1615896 (2018).","journal-title":"N Engl. J. Med."},{"issue":"15","key":"10529_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","volume":"28","author":"TM Gibson","year":"2014","unstructured":"Gibson, T. M., Morton, L. M., Shiels, M. S., Clarke, C. A. & Engels, E. A. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 28 (15), 2313\u20132318. https:\/\/doi.org\/10.1097\/QAD.0000000000000428 (2014).","journal-title":"AIDS"},{"key":"10529_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/978-1-4939-7101-5_20","volume-title":"Encyclopedia of AIDS","author":"WA Blattner","year":"2018","unstructured":"Blattner, W. A. & Nowak, R. G. Epidemiology of AIDS-Defining malignancies. In: (eds Hope, T. J., Richman, D. D. & Stevenson, M.) Encyclopedia of AIDS. Springer New York; :503\u2013513. doi:https:\/\/doi.org\/10.1007\/978-1-4939-7101-5_20 (2018)."},{"issue":"12","key":"10529_CR14","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/cancers15123191","volume":"15","author":"M Huguet","year":"2023","unstructured":"Huguet, M., Navarro, J. T., Molt\u00f3, J., Ribera, J. M. & Tapia, G. Diffuse large B-Cell lymphoma in the HIV setting. Cancers (Basel). 15 (12), 3191. https:\/\/doi.org\/10.3390\/cancers15123191 (2023).","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10529_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood-2018-01-791400","volume":"134","author":"A Noy","year":"2019","unstructured":"Noy, A. Optimizing treatment of HIV-associated lymphoma. Blood 134 (17), 1385\u20131394. https:\/\/doi.org\/10.1182\/blood-2018-01-791400 (2019).","journal-title":"Blood"},{"issue":"5","key":"10529_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24 (5), 679\u2013690. https:\/\/doi.org\/10.1038\/s41591-018-0016-8 (2018).","journal-title":"Nat. Med."},{"issue":"4","key":"10529_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright, G. W. et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 37 (4), 551\u2013568e14. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.015 (2020).","journal-title":"Cancer Cell."},{"issue":"30","key":"10529_CR18","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1200\/JCO.2008.20.5450","volume":"27","author":"A Chadburn","year":"2009","unstructured":"Chadburn, A. et al. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034. J. Clin. Oncol. 27 (30), 5039\u20135048. https:\/\/doi.org\/10.1200\/JCO.2008.20.5450 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10529_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/bjh.19531","volume":"205","author":"J Coelho","year":"2024","unstructured":"Coelho, J. et al. HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T-cell associations in diffuse large B-cell lymphoma. Br. J. Haematol. 205 (1), 194\u2013206. https:\/\/doi.org\/10.1111\/bjh.19531 (2024).","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10529_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/s41379-020-0506-3","volume":"33","author":"Y Fedoriw","year":"2020","unstructured":"Fedoriw, Y. et al. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi. Mod. Pathol. 33 (8), 1482\u20131491. https:\/\/doi.org\/10.1038\/s41379-020-0506-3 (2020).","journal-title":"Mod. Pathol."},{"issue":"13","key":"10529_CR21","doi-asserted-by":"publisher","first-page":"e180771","DOI":"10.1172\/jci.insight.180771","volume":"9","author":"SM Roush","year":"2024","unstructured":"Roush, S. M. et al. HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma. JCI Insight. 9 (13), e180771. https:\/\/doi.org\/10.1172\/jci.insight.180771 (2024).","journal-title":"JCI Insight"},{"issue":"15","key":"10529_CR22","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/cncr.32866","volume":"126","author":"MJ Lee","year":"2020","unstructured":"Lee, M. J. et al. Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. Cancer 126 (15), 3493\u20133503. https:\/\/doi.org\/10.1002\/cncr.32866 (2020).","journal-title":"Cancer"},{"issue":"11","key":"10529_CR23","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/cncr.25765","volume":"117","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy, P. J. et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the united States. Cancer 117 (11), 2530\u20132540. https:\/\/doi.org\/10.1002\/cncr.25765 (2011).","journal-title":"Cancer"},{"issue":"8","key":"10529_CR24","doi-asserted-by":"publisher","first-page":"e70361","DOI":"10.1371\/journal.pone.0070361","volume":"8","author":"S Gopal","year":"2013","unstructured":"Gopal, S. et al. Early experience after developing a pathology laboratory in malawi, with emphasis on cancer diagnoses. PLoS One. 8 (8), e70361. https:\/\/doi.org\/10.1371\/journal.pone.0070361 (2013).","journal-title":"PLoS One"},{"issue":"3","key":"10529_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.15625","volume":"184","author":"MS Painschab","year":"2019","unstructured":"Painschab, M. S. et al. Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in malawi: a prospective cohort. Br. J. Haematol. 184 (3), 364\u2013372. https:\/\/doi.org\/10.1111\/bjh.15625 (2019).","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10529_CR26","doi-asserted-by":"publisher","first-page":"e1008","DOI":"10.1016\/S2214-109X(21)00181-9","volume":"9","author":"S Kimani","year":"2021","unstructured":"Kimani, S. et al. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in malawi: a prospective, single-arm, non-randomised phase 1\/2 clinical trial. Lancet Global Health. 9 (7), e1008\u2013e1016. https:\/\/doi.org\/10.1016\/S2214-109X(21)00181-9 (2021).","journal-title":"Lancet Global Health"},{"issue":"9","key":"10529_CR27","doi-asserted-by":"publisher","first-page":"e0273408","DOI":"10.1371\/journal.pone.0273408","volume":"17","author":"Y Gondwe","year":"2022","unstructured":"Gondwe, Y. et al. Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy. PLoS One. 17 (9), e0273408. https:\/\/doi.org\/10.1371\/journal.pone.0273408 (2022).","journal-title":"PLoS One"},{"issue":"1","key":"10529_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans, C. P. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (1), 275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545 (2004).","journal-title":"Blood"},{"issue":"24","key":"10529_CR29","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.2022016095","volume":"140","author":"K Dreval","year":"2022","unstructured":"Dreval, K., Boutros, P. C. & Morin, R. D. Minimal information for reporting a genomics experiment. Blood 140 (24), 2549\u20132555. https:\/\/doi.org\/10.1182\/blood.2022016095 (2022).","journal-title":"Blood"},{"issue":"5","key":"10529_CR30","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","volume":"8","author":"EA Kautto","year":"2017","unstructured":"Kautto, E. A. et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget 8 (5), 7452\u20137463. https:\/\/doi.org\/10.18632\/oncotarget.13918 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"10529_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-014-0064-y","volume":"7","author":"C Shyr","year":"2014","unstructured":"Shyr, C. et al. FLAGS, frequently mutated genes in public exomes. BMC Med. Genomics. 7 (1), 64. https:\/\/doi.org\/10.1186\/s12920-014-0064-y (2014).","journal-title":"BMC Med. Genomics"},{"issue":"5","key":"10529_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/bjh.17708","volume":"194","author":"JR Chapman","year":"2021","unstructured":"Chapman, J. R. et al. EBV-positive HIV\u2010associated diffuse large B cell lymphomas are characterized by JAK\/STAT (STAT3) pathway mutations and unique clinicopathologic features. Br. J. Haematol. 194 (5), 870\u2013878. https:\/\/doi.org\/10.1111\/bjh.17708 (2021).","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10529_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/QAI.0000000000003069","volume":"91","author":"J Vaughan","year":"2022","unstructured":"Vaughan, J., Perner, Y. & Wiggill, T. Diffuse large B-Cell lymphoma in the Public-Sector of johannesburg, South africa, in the era of widescale antiretroviral therapy use. JAIDS J. Acquir. Immune Defic. Syndr. 91 (4), 335\u2013342. https:\/\/doi.org\/10.1097\/QAI.0000000000003069 (2022).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10529_CR34","doi-asserted-by":"publisher","unstructured":"Isshiki, Y. et al. EZH2 Inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function. Cancer Cell Published Online Dec. 2024:S1535610824004410. https:\/\/doi.org\/10.1016\/j.ccell.2024.11.006","DOI":"10.1016\/j.ccell.2024.11.006"},{"issue":"4","key":"10529_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1053\/j.seminhematol.2022.11.002","volume":"59","author":"K Lurain","year":"2022","unstructured":"Lurain, K., Ramaswami, R. & Yarchoan, R. The role of viruses in HIV-associated lymphomas. Semin Hematol. 59 (4), 183\u2013191. https:\/\/doi.org\/10.1053\/j.seminhematol.2022.11.002 (2022).","journal-title":"Semin Hematol."},{"key":"10529_CR36","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"P Shindiapina","year":"2020","unstructured":"Shindiapina, P., Ahmed, E. H., Mozhenkova, A., Abebe, T. & Baiocchi, R. A. Immunology of EBV-Related lymphoproliferative disease in HIV-Positive individuals. Front. Oncol. 10, 1723. https:\/\/doi.org\/10.3389\/fonc.2020.01723 (2020).","journal-title":"Front. Oncol."},{"issue":"5","key":"10529_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","volume":"11","author":"N Gebauer","year":"2021","unstructured":"Gebauer, N. et al. Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. Blood Cancer J. 11 (5), 102. https:\/\/doi.org\/10.1038\/s41408-021-00493-5 (2021).","journal-title":"Blood Cancer J."},{"issue":"1","key":"10529_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13000-021-01071-w","volume":"16","author":"H Ge","year":"2021","unstructured":"Ge, H. et al. Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma. Diagn. Pathol. 16 (1), 12. https:\/\/doi.org\/10.1186\/s13000-021-01071-w (2021).","journal-title":"Diagn. Pathol."},{"key":"10529_CR39","doi-asserted-by":"publisher","first-page":"101685","DOI":"10.1016\/j.tranon.2023.101685","volume":"33","author":"D Sun","year":"2023","unstructured":"Sun, D. et al. ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma. Transl Oncol. 33, 101685. https:\/\/doi.org\/10.1016\/j.tranon.2023.101685 (2023).","journal-title":"Transl Oncol."},{"issue":"7","key":"10529_CR40","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/cam4.2870","volume":"9","author":"T Tian","year":"2020","unstructured":"Tian, T. et al. Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma. Cancer Med. 9 (7), 2330\u20132342. https:\/\/doi.org\/10.1002\/cam4.2870 (2020).","journal-title":"Cancer Med."},{"issue":"2","key":"10529_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4132\/jptm.2021.10.15","volume":"56","author":"B Han","year":"2022","unstructured":"Han, B. et al. An unusual case of microsatellite instability-high\/deficient mismatch repair (MSI-H\/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing. J. Pathol. Transl Med. 56 (2), 92\u201396. https:\/\/doi.org\/10.4132\/jptm.2021.10.15 (2022).","journal-title":"J. Pathol. Transl Med."},{"issue":"14","key":"10529_CR42","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1073\/pnas.0400945101","volume":"101","author":"A Duval","year":"2004","unstructured":"Duval, A. et al. The mutator pathway is a feature of immunodeficiency-related lymphomas. Proc. Natl. Acad. Sci. USA. 101 (14), 5002\u20135007. https:\/\/doi.org\/10.1073\/pnas.0400945101 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10529_CR43","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1084\/jem.20122842","volume":"210","author":"NFCC de Miranda","year":"2013","unstructured":"de Miranda, N. F. C. C. et al. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J. Exp. Med. 210 (9), 1729\u20131742. https:\/\/doi.org\/10.1084\/jem.20122842 (2013).","journal-title":"J. Exp. Med."}],"updated-by":[{"DOI":"10.1038\/s41598-026-38395-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10529-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10529-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10529-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:03:58Z","timestamp":1770822238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10529-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10529"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10529-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-38395-w","URL":"https:\/\/doi.org\/10.1038\/s41598-026-38395-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24599"}}